Literature DB >> 31932469

PTEN as a Guardian of the Genome: Pathways and Targets.

Xinyi Fan1, Jeffrey Kraynak1, Jonathan P S Knisely1, Silvia C Formenti1,2, Wen H Shen1,2.   

Abstract

Faithful transmission of genetic information is only possible with the structural and functional integrity of the genome. PTEN has been recognized as a guardian of the genome since the identification of its noncanonical localization and function in the nucleus. Yet, the role of PTEN in guarding the genome relies on integration of diverse mechanisms elicited by its canonical activity in antagonizing PI3K as well as emerging noncanonical functions. In the nucleus, PTEN maintains the structural integrity of chromosomes and the architecture of heterochromatin by physically interacting with chromosomal and nucleosomal components. PTEN also controls the functional integrity of key genetic transmission machineries by promoting proper assembly of the replisome and mitotic spindles. Deregulation of PTEN signaling impairs genome integrity, leading to spontaneous replication/mitotic stress and subsequent stress tolerance. Identification of novel targets of PTEN signaling and illumination of the interplay of diverse PTEN pathways in genome maintenance will help us better understand mechanisms underlying tumor evolution and therapeutic resistance.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Year:  2020        PMID: 31932469      PMCID: PMC7354882          DOI: 10.1101/cshperspect.a036194

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  76 in total

1.  Systemic elevation of PTEN induces a tumor-suppressive metabolic state.

Authors:  Isabel Garcia-Cao; Min Sup Song; Robin M Hobbs; Gaelle Laurent; Carlotta Giorgi; Vincent C J de Boer; Dimitrios Anastasiou; Keisuke Ito; Atsuo T Sasaki; Lucia Rameh; Arkaitz Carracedo; Matthew G Vander Heiden; Lewis C Cantley; Paolo Pinton; Marcia C Haigis; Pier Paolo Pandolfi
Journal:  Cell       Date:  2012-03-06       Impact factor: 41.582

2.  Attenuation of PTEN perturbs genomic stability via activation of Akt and down-regulation of Rad51 in human embryonic kidney cells.

Authors:  Ananda Mukherjee; Parimal Karmakar
Journal:  Mol Carcinog       Date:  2012-04-04       Impact factor: 4.784

3.  PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells.

Authors:  Janusz Puc; Ramon Parsons
Journal:  Cell Cycle       Date:  2005-07-03       Impact factor: 4.534

4.  PTEN C-terminal deletion causes genomic instability and tumor development.

Authors:  Zhuo Sun; Chuanxin Huang; Jinxue He; Kristy L Lamb; Xi Kang; Tingting Gu; Wen Hong Shen; Yuxin Yin
Journal:  Cell Rep       Date:  2014-02-20       Impact factor: 9.423

5.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

Review 6.  HDACs and HDAC Inhibitors in Cancer Development and Therapy.

Authors:  Yixuan Li; Edward Seto
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 7.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

8.  PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.

Authors:  Prerna Malaney; Emily Palumbo; Jonathan Semidey-Hurtado; Jamaal Hardee; Katherine Stanford; Jaymin J Kathiriya; Deepal Patel; Zhi Tian; Diane Allen-Gipson; Vrushank Davé
Journal:  Cell Cycle       Date:  2018-05-31       Impact factor: 4.534

9.  Mechanistic Rationale to Target PTEN-Deficient Tumor Cells with Inhibitors of the DNA Damage Response Kinase ATM.

Authors:  Nuala McCabe; Conor Hanna; Steven M Walker; David Gonda; Jie Li; Katarina Wikstrom; Kienan I Savage; Karl T Butterworth; Clark Chen; D Paul Harkin; Kevin M Prise; Richard D Kennedy
Journal:  Cancer Res       Date:  2015-04-13       Impact factor: 12.701

Review 10.  Epigenetic mechanisms as a new approach in cancer treatment: An updated review.

Authors:  Masoumeh Fardi; Saeed Solali; Majid Farshdousti Hagh
Journal:  Genes Dis       Date:  2018-06-18
View more
  7 in total

1.  Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.

Authors:  Vivian S Park; Meijuan J S Sun; Wesley D Frey; Leonard G Williams; Karl P Hodel; Juliet D Strauss; Sydney J Wellens; James G Jackson; Zachary F Pursell
Journal:  NAR Cancer       Date:  2022-03-03

2.  Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.

Authors:  Takae Brewer; Lamis Yehia; Peter Bazeley; Charis Eng
Journal:  Am J Hum Genet       Date:  2022-08-04       Impact factor: 11.043

3.  Effect of miR-144-3p-Targeted Regulation of PTEN on Proliferation, Apoptosis, and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells under Stretch.

Authors:  Shiyong Ling; Xi Luo; Bo Lv; Hua Wang; Mengzhi Xie; Kai Huang; Jingchuan Sun
Journal:  Emerg Med Int       Date:  2022-05-10       Impact factor: 1.621

Review 4.  PTEN in Hereditary and Sporadic Cancer.

Authors:  Joanne Ngeow; Charis Eng
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

Review 5.  PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Authors:  Nicola Fusco; Elham Sajjadi; Konstantinos Venetis; Gabriella Gaudioso; Gianluca Lopez; Chiara Corti; Elena Guerini Rocco; Carmen Criscitiello; Umberto Malapelle; Marco Invernizzi
Journal:  Genes (Basel)       Date:  2020-06-28       Impact factor: 4.096

6.  Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling.

Authors:  Elham Sajjadi; Konstantinos Venetis; Roberto Piciotti; Donatella Gambini; Concetta Blundo; Letterio Runza; Stefano Ferrero; Elena Guerini-Rocco; Nicola Fusco
Journal:  BMC Cancer       Date:  2021-10-28       Impact factor: 4.430

7.  Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers.

Authors:  Ilya G Serebriiskii; Valery Pavlov; Rossella Tricarico; Grigorii Andrianov; Emmanuelle Nicolas; Mitchell I Parker; Justin Newberg; Garrett Frampton; Joshua E Meyer; Erica A Golemis
Journal:  Nat Commun       Date:  2022-03-25       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.